The panel that advises the Centers for Disease Control and Prevention (CDC) on vaccines will meet to discuss how to handle the newly approved Moderna COVID-19 vaccine. The formal name of the panel is the Advisory Committee on Immunization Practices (ACIP). “ACIP will meet (as they did when they recommended the Pfizer vaccine after approval),” a CDC spokesman told The Epoch Times in an email shortly after the Food and Drug Administration (FDA) approved Moderna’s shot. No details were immediately available as to the timing of the meeting. After Pfizer’s COVID-19 vaccine was approved in August 2021, ACIP convened and heard from officials from Pfizer and the CDC concerning the safety and effectiveness of the jab. The panel ultimately decided to change an interim recommendation for all Americans 16 and older to get the vaccine to a standard recommendation. Use of the vaccine “is recommended based on increased certainty that its benefits (prevention …